Introduction
It is considered unethical for manufacturers to design prospective human trials to ascertain potential teratogenicity or to determine dangers to a baby when medications pass into breast milk.[1] Thus, pregnant and lactating females are often referred to as therapeutic orphans. Many of these patients choose nonprescription products on their own.[2] However, even when women do ask, pharmacists are hampered by the general lack of knowledge regarding the potential dangers of these products.
US Pharmacist. 2007;32(9):10-14. © 2007 Jobson Publishing
Comments